Susquehanna Fundamental Investments, LLC Magenta Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.07 - $9.89 $303,081 - $493,817	-49,931 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$9.76 - $14.15 $10,736 - $15,565	-1,100 Reduced 2.16%	49,931 $488,000
Q1 2021 May 17, 2021	SELL	$7.66 - $13.38 $32,064 - $56,008	-4,186 Reduced 7.58%	51,031 $604,000
Q4 2020 Feb 16, 2021	SELL	$6.1 - $7.94 $72,486 - $94,351	-11,883 Reduced 17.71%	55,217 $433,000
Q3 2020 Nov 16, 2020	BUY	$6.52 - $8.94 $437,492 - $599,874	67,100 New	67,100 $456,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.